•
Jan 31, 2018

Summit Therapeutics Q4 2018 Earnings Report

Total Revenue
$663K
EPS
-$0.08
Gross Profit
$2.28M
Cash and Equivalents
$28.5M
Free Cash Flow
-$22.2M
Total Assets
$78.2M

Summit Therapeutics

Summit Therapeutics